Skip to content

Ascendis Pharma A/S

US · ASND #1127 by market cap Listed 2015
252.73 -3.23 -1.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Founded
2006
CEO
Mr. Jan Moller Mikkelsen
Employees
1,189
Headquarters
Hellerup, Capital Region, Denmark
Fiscal year end
12-31
Website
ascendispharma.com

Company profile

Exchange
US
Symbol
ASND
Market-cap rank
#1127
Listing date
2015-01-28
Market cap
16.63B
Float cap
16.62B
Shares out
65.80M
Float shares
65.77M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Ascendis Pharma A/S discussion 0 comments

Add a comment